| 000 | 01260nam a22002177a 4500 | ||
|---|---|---|---|
| 005 | 20240113110609.0 | ||
| 008 | 240113b |||||||| |||| 00| 0 eng d | ||
| 020 | _a9780128144251 | ||
| 050 |
_aAllied RM 301.4 _bB56 2021 |
||
| 245 |
_aBiopharmaceutics and pharmacokinetics considerations / _cEdited by Rakesh Kumar Tekade |
||
| 264 |
_aU.K. : _bAcademic Press , _c2021. |
||
| 300 |
_axix, 732 pages : _bcolored illustration ; _c23 cm. |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | _aOverview of biopharmaceutics and pharmacokinetics -- Pharmacokinetics and biopharmaceutics: "a leader or attendant" -- Dose, dosage regimen, and dose adjustment in organ failure -- pharmacokinetics aspects of structural modification in drug design and therapy -- Biopharmaceutical considerations in the pediatric and geriatric formulation development -- kinetics of maternal-fetal drug transfer -- Chronopharmacokinetic -- Pharmacokinetics characterization of drugs and new product development -- Pharmacokinetics modeling in drug delivery. | ||
| 650 | _aBiopharmaceutics | ||
| 650 | _aPharmacokinetics | ||
| 942 |
_2lcc _cBK _kEAC Cavite-Allied |
||
| 999 |
_c94442 _d94442 |
||